Skip to main content
Sean Khozin, MD, Oncology, New York, NY

SeanKhozinMDMPH

Oncology New York, NY

Physician

Dr. Khozin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Khozin's full profile

Already have an account?

  • Office

    80 N Moore St
    Apt #8g
    New York, NY 10013
    Phone+1 646-543-0763

Education & Training

  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2004

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2025

Publications & Presentations

PubMed

Lectures

  • Real-world characteristics and outcomes of patients with advanced non-small cell lung cancer (aNSCLC) receiving immune checkpoint inhibitor. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • Real-world outcomes of patients with advanced non-small cell lung cancer (aNSCLC) and autoimmune disease (AD) receiving immune checkpoint inhibitors (ICIs). 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • FDA's Informed: Real-World Evidence Comes of Age 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

  • CancerLinQ and Owkin Collaborate to Use Federated Learning on Real-World Oncology Data in a Study to Understand Lung Cancer Treatment
    CancerLinQ and Owkin Collaborate to Use Federated Learning on Real-World Oncology Data in a Study to Understand Lung Cancer TreatmentJuly 7th, 2022
  • How Do Patients Feel About AI in Health Care? It Depends
    How Do Patients Feel About AI in Health Care? It DependsMay 6th, 2022
  • ASCO’s CancerLinQ® and Count Me in Collaborate to Empower Patient Participation in Clinical Cancer Research
    ASCO’s CancerLinQ® and Count Me in Collaborate to Empower Patient Participation in Clinical Cancer ResearchApril 5th, 2022
  • Join now to see all